Insiders · Profile

Hagerman Allison

VP, Product Development at ONCOLYTICS BIOTECH. Filing since 12 Feb 2026. CIK 0002103583

Company

Date

Role

Action

Amount

Of holding

12 Feb 2026

VP, Product Development

Bought

10,000

$8.30K

9.5%

1 decision on file.